• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非甾体抗炎药与对乙酰氨基酚治疗膝和髋关节骨关节炎:关于影响结局的异质性的系统评价。

NSAIDs vs acetaminophen in knee and hip osteoarthritis: a systematic review regarding heterogeneity influencing the outcomes.

机构信息

Department of General Practice, Erasmus MC, University Medical Center Rotterdam, the Netherlands.

出版信息

Osteoarthritis Cartilage. 2011 Aug;19(8):921-9. doi: 10.1016/j.joca.2011.04.013. Epub 2011 May 12.

DOI:10.1016/j.joca.2011.04.013
PMID:21619937
Abstract

OBJECTIVE

To identify sources of heterogeneity (statistical, methodological, and clinical) in studies evaluating non-steroidal anti-inflammatory drugs (NSAIDs) vs acetaminophen in patients with knee and hip osteoarthritis (OA) to elucidate variations in outcomes.

METHOD

A database search (1966 to January 2010) was made for (randomized) controlled trials ((R)CTs) comparing NSAIDs vs acetaminophen in knee and hip OA. Extracted data included baseline demographic/clinical characteristics, outcomes at follow-up, and characteristics of study design. Heterogeneity was examined with subgroup analyses by exploring changes in effect size and with I(2) of Higgins. Pain measures were expressed as standardized mean differences.

RESULTS

15 RCTs, including 21 comparisons of NSAIDs and acetaminophen were included. Statistical heterogeneity was absent (Cochran's Q-test=14.11; I(2)=0; P=0.78). Moderate clinical heterogeneity was found for comparisons which included both hip and knee OA vs knee OA only (I(2)=51; P=0.09). NSAIDs seemed slightly more effective than acetaminophen if more patients with hip OA were included. However, the pooled effect sizes of comparisons with knee OA vs both knee and hip OA are equal. Low clinical heterogeneity was found for comparisons with low dosage of acetaminophen, normal dosage of NSAIDs, and moderate pain intensity at baseline. Low methodological heterogeneity was found for comparisons with a short duration.

CONCLUSION

Future trials should present the results of hip and knee OA separately, as moderate clinical heterogeneity was found. There might be differences in effectiveness of NSAIDs vs acetaminophen in patients with hip vs knee OA. No significant methodological and statistical heterogeneity was found in studies evaluating NSAIDs vs acetaminophen.

摘要

目的

确定评估膝关节和髋关节骨关节炎(OA)患者中 NSAIDs 与对乙酰氨基酚的疗效的研究中(统计学、方法学和临床)异质性的来源,以阐明结局的差异。

方法

对数据库(1966 年至 2010 年 1 月)进行检索,查找比较 NSAIDs 与对乙酰氨基酚治疗膝关节和髋关节 OA 的(随机)对照试验(RCT)。提取的数据包括基线人口统计学/临床特征、随访时的结局以及研究设计的特征。通过亚组分析,通过探索效应大小的变化和 Higgins 的 I²来检查异质性。疼痛测量以标准化均数差值表示。

结果

共纳入 15 项 RCT,包括 21 项 NSAIDs 与对乙酰氨基酚的比较。未发现统计学异质性(Cochran's Q 检验=14.11;I²=0;P=0.78)。对于包括髋关节和膝关节 OA 与仅膝关节 OA 的比较,发现存在中度临床异质性(I²=51;P=0.09)。如果包括更多髋关节 OA 患者,NSAIDs 似乎比对乙酰氨基酚更有效。然而,与膝关节 OA 相比,与膝关节和髋关节 OA 相比的 pooled 效应大小相等。对于低剂量对乙酰氨基酚、正常剂量 NSAIDs 和基线时中度疼痛强度的比较,发现临床异质性较低。对于持续时间较短的比较,发现方法学异质性较低。

结论

未来的试验应分别报告髋关节和膝关节 OA 的结果,因为发现了中度临床异质性。在髋关节 OA 与膝关节 OA 患者中,NSAIDs 与对乙酰氨基酚的疗效可能存在差异。在评估 NSAIDs 与对乙酰氨基酚的研究中,未发现明显的方法学和统计学异质性。

相似文献

1
NSAIDs vs acetaminophen in knee and hip osteoarthritis: a systematic review regarding heterogeneity influencing the outcomes.非甾体抗炎药与对乙酰氨基酚治疗膝和髋关节骨关节炎:关于影响结局的异质性的系统评价。
Osteoarthritis Cartilage. 2011 Aug;19(8):921-9. doi: 10.1016/j.joca.2011.04.013. Epub 2011 May 12.
2
WITHDRAWN: Non-aspirin, non-steroidal anti-inflammatory drugs for treating osteoarthritis of the knee.撤回:用于治疗膝关节骨关节炎的非阿司匹林非甾体抗炎药。
Cochrane Database Syst Rev. 2007 Jul 18;2006(1):CD000142. doi: 10.1002/14651858.CD000142.pub2.
3
Celecoxib for osteoarthritis.塞来昔布用于骨关节炎
Cochrane Database Syst Rev. 2017 May 22;5(5):CD009865. doi: 10.1002/14651858.CD009865.pub2.
4
Acetaminophen for osteoarthritis.对乙酰氨基酚用于骨关节炎
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD004257. doi: 10.1002/14651858.CD004257.pub2.
5
Acetaminophen for osteoarthritis.对乙酰氨基酚用于骨关节炎
Cochrane Database Syst Rev. 2003(2):CD004257. doi: 10.1002/14651858.CD004257.
6
Acupuncture for hip osteoarthritis.针灸治疗髋骨关节炎
Cochrane Database Syst Rev. 2018 May 5;5(5):CD013010. doi: 10.1002/14651858.CD013010.
7
Antidepressants for hip and knee osteoarthritis.抗抑郁药治疗髋膝关节骨关节炎。
Cochrane Database Syst Rev. 2022 Oct 21;10(10):CD012157. doi: 10.1002/14651858.CD012157.pub2.
8
Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children.对乙酰氨基酚(醋氨酚)或非甾体抗炎药单独使用或联合使用,用于缓解儿童急性中耳炎的疼痛。
Cochrane Database Syst Rev. 2016 Dec 15;12(12):CD011534. doi: 10.1002/14651858.CD011534.pub2.
9
Non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the knee.用于膝关节骨关节炎的非阿司匹林非甾体抗炎药。
Cochrane Database Syst Rev. 2000(2):CD000142. doi: 10.1002/14651858.CD000142.
10
WITHDRAWN: Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip.撤回:用于髋关节骨关节炎的镇痛及非阿司匹林、非甾体类抗炎药
Cochrane Database Syst Rev. 2007 Jul 18(1):CD000517. doi: 10.1002/14651858.CD000517.pub2.

引用本文的文献

1
The Interplay of Aging and PANoptosis in Osteoarthritis Pathogenesis: Implications for Novel Therapeutic Strategies.衰老与PAN细胞焦亡在骨关节炎发病机制中的相互作用:对新型治疗策略的启示
J Inflamm Res. 2025 Feb 10;18:1951-1967. doi: 10.2147/JIR.S489613. eCollection 2025.
2
Significance of Necroptosis in Cartilage Degeneration.细胞程序性坏死在软骨退变中的意义。
Biomolecules. 2024 Sep 21;14(9):1192. doi: 10.3390/biom14091192.
3
Evidence-Based Review of Nonsurgical Treatments for Knee and Hip Osteoarthritis.膝关节和髋关节骨关节炎非手术治疗的循证综述
Eur J Rheumatol. 2024 Mar 25;11(Suppl 1):S48-52. doi: 10.5152/eurjrheum.2024.22096.
4
Comparative effectiveness of early initiation of oral nonsteroidal anti-inflammatory drug and oral acetaminophen therapies on the time to knee replacement in patients with knee osteoarthritis in Japan.在日本,膝骨关节炎患者中,早期开始口服非甾体抗炎药和口服对乙酰氨基酚治疗对膝关节置换时间的比较效果。
BMC Musculoskelet Disord. 2023 Apr 14;24(1):297. doi: 10.1186/s12891-023-06415-9.
5
Paracetamol: A Review of Guideline Recommendations.对乙酰氨基酚:指南推荐综述
J Clin Med. 2021 Jul 31;10(15):3420. doi: 10.3390/jcm10153420.
6
Efficacy and Safety of Sahastara Remedy Extract Capsule in Primary Knee Osteoarthritis: A Randomized Double-Blinded Active-Controlled Trial.萨哈斯塔拉疗法提取物胶囊治疗原发性膝骨关节炎的疗效与安全性:一项随机双盲活性对照试验
Evid Based Complement Alternat Med. 2021 Jan 18;2021:6635148. doi: 10.1155/2021/6635148. eCollection 2021.
7
The Efficacy of a Lateral Wedge Insole for Painful Medial Knee Osteoarthritis After Prescreening: A Randomized Clinical Trial.外侧楔形鞋垫对内侧膝骨关节炎疼痛的疗效:一项预筛选后的随机临床试验。
Arthritis Rheumatol. 2019 Jun;71(6):908-915. doi: 10.1002/art.40808. Epub 2019 Apr 8.
8
Emerging Treatment Models in Rheumatology: Challenges for Osteoarthritis Trials.风湿病学中的新兴治疗模式:骨关节炎试验面临的挑战。
Arthritis Rheumatol. 2018 Aug;70(8):1175-1181. doi: 10.1002/art.40515. Epub 2018 Jun 6.
9
Mefenamic acid decreases inflammation but not joint lesions in experimental osteoarthritis.甲芬那酸可减轻实验性骨关节炎的炎症,但不能减轻关节损伤。
Int J Exp Pathol. 2016 Dec;97(6):438-446. doi: 10.1111/iep.12216.
10
Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review.口服非甾体抗炎药和阿片类药物治疗膝骨关节炎的镇痛效果比较:系统分析综述。
Osteoarthritis Cartilage. 2016 Jun;24(6):962-72. doi: 10.1016/j.joca.2016.01.135. Epub 2016 Feb 1.